On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayNov 30, 2021 3:11 pm

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Ranking Amongst Rarest of Companies

Tingo (OTCQB: IWBB) recently applied to list its shares for trading with the New York Stock Exchange (“NYSE”), forming part of efforts to broaden its appeal to U.S. and international investors. Although there are no guarantees that its listing application will be accepted, the company has reiterated its belief that it will satisfy the NYSE’s initial listing criteria. A recent article quotes Tingo CEO Dozy Mmobuosi as saying: “The NYSE is the main stock exchange in the United States and one that will raise our profile to the broader investment community. The bottom-up list will increase liquidity in our stocks…

Continue Reading

TuesdayNov 30, 2021 2:06 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Q3 2021 Report Showing 1,000% Increase in Revenues

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has released its  unaudited financial results for the quarter ended Sept. 30, 2021; all numbers are in Canadian dollars. Among the highlights include a revenue growth figure of $1.1 million, which represents more than a 1,000% increase over the $94,000 reported in the same quarter last year. In addition, the company noted gross profit of $356,168 during Q3 2021, compared to a loss of $40,280 for Q3 2020. BevCanna closed the quarter with cash reserves of $655,563. Business highlights include a…

Continue Reading

TuesdayNov 30, 2021 1:55 pm

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Enters Definitive Acquisition Agreement for High-Grade Bonanza Gold Mine Project

Asia Broadband (OTC: AABB) today announced its entry into a definitive purchase agreement to acquire a 100% interest in the Bonanza Gold Mine Project. According to the update, the company came to terms with Martin Augusto Vallejo Lujambio for the 19.25-hectare concession # 221977, Bonanza, located approximately 48 kms southeast from the city of Acaponeta and 3 kms from the town of El Carrizo, in Nayarit, Mexico. The property’s total purchase price was $6 million, split into $ 2 million cash and $ 4 million in restricted shares of Asia Broadband. The project is another prospective high-yield asset addition in…

Continue Reading

TuesdayNov 30, 2021 1:39 pm

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Announces Participation in Sports Betting, iGaming Summit

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, will be participating in the upcoming Jefferies Sports Betting and iGaming Summit. The summit, scheduled to take place on Dec. 2, 2021, will include a fireside chat, which will include Lottery.com cofounder and CEO Tony DiMatteo. The chat will begin at 4 p.m. ET. In addition, DiMatteo will be available to meet with conference attendees. An archived replay of DiMatteo’s presentation will be available for 30 days. Lottery.com is dedicated offering mobile and online platforms that support players and commercial globally…

Continue Reading

TuesdayNov 30, 2021 1:05 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key FDA Approvals, Participation in Psychedelics Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received authorization from the U.S. Food and Drug Administration (“FDA”) for an investigator-initiated, randomized, placebo-controlled phase 2 clinical trial; the trial is designed to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress. The company noted that the primary investigator for the trial, Dr. Anthony Back, received an investigational new drug ("IND") approval letter from the FDA, authorizing the trial. In addition, the study has received Institutional Review Board (“IRB”) approval at the University of Washington. Cybin also announced that CEO Doug Drysdale…

Continue Reading

TuesdayNov 30, 2021 12:10 pm

QualityStocksNewsBreaks– Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Benzinga Global Small Cap Conference

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that its CEO Faz Chowdhury, Ph.D., will present at the Benzinga Global Small Cap Conference. The event is scheduled to be held virtually from Dec. 8-9, 2021. Dr. Chowdhury will deliver his corporate presentation at 3:00 p.m. ET on Dec. 8 and will be available for one-on-one meetings throughout the conference. Interested parties should visit https://ibn.fm/puHmj to register for the event. To view the full press release, visit https://ibn.fm/RJcQX About Nemaura Medical Inc. Nemaura Medical…

Continue Reading

TuesdayNov 30, 2021 11:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Strategy Toward Potential Therapeutics for Diseases with High Unmet Needs

InMed Pharmaceuticals (NASDAQ: INM) recently filed a Patent Cooperation Treaty (“PCT”) application, which specifies a rare cannabinoid (new to InMed’s portfolio) that may inhibit or slow the progression of neurogenerative diseases – such as Alzheimer’s, Parkinson’s, Huntington’s and others – by providing protection in a population of affected neurons. Furthermore, the application demonstrates the cannabinoid can also be used to promote neurite outgrowth, signifying the potential to enhance neuronal function. According to InMed’s Senior VP Pre-Clinical Research & Development Dr. Eric Hsu, who is quoted in a recent article, “This PCT patent application advances our strategy directed towards researching and…

Continue Reading

TuesdayNov 30, 2021 11:25 am

QualityStocksNewsBreaks – Why Mullen Automotive Inc. (NASDAQ: MULN) Is ‘One to Watch’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, owns and partners with multiple synergistic businesses working to create clean and scalable energy solutions. Led by an executive team with extensive EV, OEM and high-growth startup experience, Mullen has evolved over the past decade in sync with technology trends and consumers. The company is working diligently to provide innovative EV options built entirely in the U.S. Its Mullen FIVE EV Crossover, which debuted at the Los Angeles International Auto Show (“LAIAS”) in November 2021, is built on an EV crossover skateboard platform that offers multiple powertrain configurations and trim…

Continue Reading

TuesdayNov 30, 2021 10:27 am

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q3 2021 Results, Including 93% YOY Revenue Increase

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced 2021 third quarter financial results. Among the highlights, the company reported a 93% increase in third quarter year-over-year revenue. “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan and California to become more vertically integrated where it will be most profitable,” said Brad Rogers, RWB chairman and CEO. “This will help drive increased revenue and margins for the company. Simultaneously, we are gaining significant market share with our…

Continue Reading

TuesdayNov 30, 2021 9:32 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Second-Quarter 2022 Financial Report

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is reporting its interim unaudited consolidated financial results for the three and six months ended Sept. 30, 2021. Highlights of the report include an increase of gross revenue and gross margin; all figures are in Canadian dollars. PlantX gross revenue for the three-month period ended Sept. 30 totaled $2,826,790, an increase of $2,499,788 from the gross revenue generated for the same period in 2020, with gross margin of $1,292,963, compared to $15,913 for the same period in 2020. In addition, the company reported cost of sales reaching $1,533,827 with net loss of $7,617,163 —  $3,394,397 of that amount was the result…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered